- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/116 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulfur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring
Patent holdings for IPC class C07D 295/116
Total number of patents in this class: 44
10-year publication summary
8
|
5
|
2
|
5
|
1
|
2
|
2
|
2
|
2
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
PTC Therapeutics, Inc. | 468 |
4 |
Orsobio, Inc. | 11 |
3 |
Xenthera, Inc. | 4 |
3 |
Novartis AG | 11068 |
2 |
University of Florida Research Foundation, Inc. | 3966 |
2 |
VM Oncology LLC | 4 |
2 |
Suzhou Pharmavan Cancer Research Center Co., Ltd. | 9 |
2 |
F. Hoffmann-La Roche AG | 7881 |
1 |
Genentech, Inc. | 3864 |
1 |
Boehringer Ingelheim International GmbH | 4726 |
1 |
Centre National de La Recherche Scientifique | 10128 |
1 |
FUJIFILM Corporation | 28979 |
1 |
California Institute of Technology | 3943 |
1 |
DSM IP Assets B.V. | 5568 |
1 |
The Johns Hopkins University | 5554 |
1 |
Actelion Pharmaceuticals Ltd | 537 |
1 |
Adeka Corporation | 1352 |
1 |
Georgia State University Research Foundation, Inc. | 339 |
1 |
Pharmaxis Ltd | 39 |
1 |
Ruprecht-Karls-Universität Heidelberg | 247 |
1 |
Other owners | 13 |